Scientia Pharmaceutica · 2019 · 244 citations · 149 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryNanoparticle Drug DeliveryBlood-brain Barrier DeliveryBlood-brain Barrier PenetrationLipid-based NanoparticlesNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsBlood - Brain Barrier ModelsBlood-brain Barrier AnatomyBlood-brain Barrier Drug TransportBlood-brain Barrier ModelsBlood-brain Barrier PermeabilityHuman Blood-brain Barrier ModelsIntranasal AdministrationTargeted Delivery Across The Blood-brain Barrier
Treatment of certain central nervous system disorders, including different types of cerebral malignancies, is limited by traditional oral or systemic administrations of therapeutic drugs due to possible serious side effects and/or lack of the brain penetration and, therefore, the efficacy of the drugs is diminished. During the last decade, several new technologies were developed to overcome barrier properties of cerebral capillaries. This review gives a short overview of the structural elements and anatomical features of the blood–brain barrier. The various in vitro (static and dynamic), in vivo (microdialysis), and in situ (brain perfusion) blood–brain barrier models are also presented. The drug formulations and administration options to deliver molecules effectively to the central nervous system (CNS) are presented. Nanocarriers, nanoparticles (lipid, polymeric, magnetic, gold, and carbon based nanoparticles, dendrimers, etc.), viral and peptid vectors and shuttles, sonoporation and microbubbles are briefly shown. The modulation of receptors and efflux transporters in the cell membrane can also be an effective approach to enhance brain exposure to therapeutic compounds. Intranasal administration is a noninvasive delivery route to bypass the blood–brain barrier, while direct brain administration is an invasive mode to target the brain region with therapeutic drug concentrations locally. Nowadays, both technological and mechanistic tools are available to assist in overcoming the blood–brain barrier. With these techniques more effective and even safer drugs can be developed for the treatment of devastating brain disorders.
149
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
Mihaela Crisan, Solomon Yap, Louis Casteilla et al. · Cell stem cell · 2008 · 4K citations · Full text
Life Sciences, Anatomy, Cell Biology +10
Sangeeta N. Bhatia, Donald E. Ingber · Nature Biotechnology · 2014 · 3.2K citations
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Steven R. Schwarze, Alan L. Ho, Adamina Vocero-Akbani et al. · Science · 1999 · 2.4K citations